These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28813465)

  • 1. Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
    Yang JH; Li XY; Wang X; Hou WJ; Qiu XS; Wang EH; Wu GP
    PLoS One; 2017; 12(8):e0182775. PubMed ID: 28813465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
    Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
    Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7.
    Hu Y; Wu MZ; Gu NJ; Xu HT; Li QC; Wu GP
    Thorac Cancer; 2020 Nov; 11(11):3175-3180. PubMed ID: 32945133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells.
    Shao JS; Sun J; Wang S; Chung K; Du JT; Wang J; Qiu XS; Wang EH; Wu GP
    Tumour Biol; 2017 Jul; 39(7):1010428317717137. PubMed ID: 28720067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
    Oh ST; Kyo S; Laimins LA
    J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
    Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
    Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 E6/E7 upregulate hTERC mRNA and gene amplification levels by relieving the effect of LKB1 on Sp1 phosphorylation in lung cancer cells.
    Yang JH; Wu MZ; Wang XB; Wang S; Qiu XS; Wang EH; Wu GP
    Ther Adv Med Oncol; 2020; 12():1758835920917562. PubMed ID: 32499837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
    Katzenellenbogen RA; Egelkrout EM; Vliet-Gregg P; Gewin LC; Gafken PR; Galloway DA
    J Virol; 2007 Apr; 81(8):3786-96. PubMed ID: 17267499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
    Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
    J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
    Li F; Cui J
    Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300.
    James MA; Lee JH; Klingelhutz AJ
    Int J Cancer; 2006 Oct; 119(8):1878-85. PubMed ID: 16708385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
    Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
    Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes.
    Xu M; Katzenellenbogen RA; Grandori C; Galloway DA
    Virology; 2013 Nov; 446(1-2):17-24. PubMed ID: 24074563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
    Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
    Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.
    Gewin L; Myers H; Kiyono T; Galloway DA
    Genes Dev; 2004 Sep; 18(18):2269-82. PubMed ID: 15371341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein.
    Veldman T; Horikawa I; Barrett JC; Schlegel R
    J Virol; 2001 May; 75(9):4467-72. PubMed ID: 11287602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
    Tiwari D; Ray Das C; Sultana R; Kakoti S; Aasif Khan M; Dongre A; Husain SA; Bose PD; Bose S
    J Cell Biochem; 2020 Apr; 121(4):2782-2791. PubMed ID: 31692038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes.
    Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
    J Virol; 2009 Jul; 83(13):6446-56. PubMed ID: 19369336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1.
    Liang X; Li ZL; Jiang LL; Guo QQ; Liu MJ; Nan KJ
    Int J Oncol; 2014 Jun; 44(6):1989-97. PubMed ID: 24647869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.